Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the study showed that approximately…
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the study showed that approximately…